Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CSPC Pharmaceutical Group ( (HK:1093) ) has shared an announcement.
CSPC Pharmaceutical Group announced that its subsidiary, CSPC Innovation Pharmaceutical Co., Ltd., has submitted an application for an H Share Listing on the Stock Exchange. This move is part of CSPC’s strategy to enhance its market presence and leverage capital markets for growth. The listing is subject to regulatory approvals and market conditions, and the company has cautioned stakeholders about the uncertainties involved.
The most recent analyst rating on (HK:1093) stock is a Buy with a HK$12.40 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group is a Hong Kong-based company operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products, with a market focus on innovation and expansion in the healthcare sector.
Average Trading Volume: 132,699,927
Technical Sentiment Signal: Buy
Current Market Cap: HK$86.16B
See more data about 1093 stock on TipRanks’ Stock Analysis page.